Biogen MA Inc., commonly referred to as Biogen, is a leading biotechnology company headquartered in the United States. Founded in 1978, Biogen has established itself as a pioneer in the development of therapies for neurological diseases, with a strong focus on multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease. With major operational regions across North America, Europe, and Asia, Biogen is renowned for its innovative products, including the first approved treatment for spinal muscular atrophy. The company’s commitment to research and development has positioned it as a key player in the biotechnology industry, achieving significant milestones such as the launch of groundbreaking therapies that address unmet medical needs. Biogen's dedication to advancing neuroscience continues to drive its market leadership and influence in the biopharmaceutical sector.
We don't have data for Biogen MA Inc., but we can show you information about their parent organization instead.
View parent company